CVS Health Corp. has recently shared some promising news about its financial future. The company has increased its profit expectations for the full year and has even given a sneak peek into its earnings for 2026. This is a positive sign for CVS as it faces challenges in the retail sector and deals w
CVS Health has been making waves with its recent announcements. The company shared its future plans during an investor event on Tuesday. This has led to a significant increase in its stock price. So, what's driving this surge? First off, CVS has big expectations for its revenue. By 2025, they aim t
CVS has introduced a new rule for COVID-19 vaccines in 14 states, including New York. Now, you need a prescription to get the updated shot. This change comes as the federal health officials have stopped recommending the vaccine for everyone over 6 months old. The updated COVID-19 vaccines have been
CVS Health, a company that had a rough 2024, is showing signs of a comeback. Investors are taking notice, especially after the company's impressive fourth-quarter earnings report. Shares of CVS have surged by over 45% this year, outperforming rivals like Walgreens, which has only seen a 3% increase.
CVS Health Corporation recently shared its financial performance for the final quarter and the entire year of 2024. The earnings per share (EPS) for the fourth quarter, following Generally Accepted Accounting Principles (GAAP), dropped to $1. 30 from $1. 58 the previous year. This decrease was mainl
The Justice Department has started a fight with CVS Pharmacy, claiming they've been filling prescriptions that break the law. These aren't just any prescriptions, though – we're talking about dangerous amounts of opioids, and sometimes even mixes of drugs that aren't safe. Plus, they allegedly got p
The US Department of Justice has sued CVS, claiming the pharmacy chain filled illegal opioid prescriptions and billed federal health programs. The complaint, filed in Rhode Island, says CVS violated the Controlled Substances Act by dispensing large quantities and dangerous combinations of opioids fr
CVS Health has bolstered its board of directors, adding four new members, including the CEO of a hedge fund that has been vocal about the company’s struggles. The latest development comes after productive discussions with shareholder Glenview Capital Management, which holds about a 1% stake in CVS H
CVS Health had a mixed third quarter, with increased medical costs hurting profits. This is the first report under new CEO David Joyner, who's trying to turn things around. The company expects these costs to stay high until the end of the year. They wouldn't give a formal outlook, but will share som
CVS Health is facing a challenge. Their stock prices are falling, and healthcare costs are skyrocketing. The money coming in from their pharmacy services isn't enough. To tackle this, they're thinking about a significant change: splitting their retail stores from their health insurance business. The
